Literature DB >> 28744397

Long non-coding RNA DGCR5 is involved in the regulation of proliferation, migration and invasion of lung cancer by targeting miR-1180.

En-Guo Chen1, Ji-Song Zhang1, Shan Xu1, Xiao-Jing Zhu1, Hui-Hui Hu1.   

Abstract

Accumulating studies have demonstrated that non-coding RNAs (ncRNAs), including small non-coding RNAs (small ncRNAs) and long non-coding RNAs (lncRNAs), are involved in tumor growth in lung cancer (LC). However, the specific role of DGCR5 in LC progression is not yet clear. In the present study, we found that DGCR5 was downregulated and miR-1180 was upregulated in the sera and tissues of LC patients and was correlated with poor prognosis. We also found that DGCR5 suppressed proliferation, migration and invasion of LC cell lines H520 and H1299. In addition, a luciferase reporter gene assay was used to investigate the regulatory relationship between DGCR5 and miR-1180. Furthermore, we suggested that DGCR5 inhibited the expression of AKT, GSK-3β, and β-catenin by targeting miR-1180. Based on these findings, DGCR5 might serve as a potential target for the development of effective anti-neoplastic therapies in lung cancer.

Entities:  

Keywords:  Long non-coding RNA DGCR5; lung cancer; miR-1180; migration and invasion

Year:  2017        PMID: 28744397      PMCID: PMC5523028     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  45 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

Review 2.  Regulation of the mammalian epigenome by long noncoding RNAs.

Authors:  Joanne Whitehead; Gaurav Kumar Pandey; Chandrasekhar Kanduri
Journal:  Biochim Biophys Acta       Date:  2008-10-30

3.  Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.

Authors:  Sharon Amit; Ada Hatzubai; Yaara Birman; Jens S Andersen; Etti Ben-Shushan; Matthias Mann; Yinon Ben-Neriah; Irit Alkalay
Journal:  Genes Dev       Date:  2002-05-01       Impact factor: 11.361

4.  Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.

Authors:  Yasutaka Sukawa; Hiroyuki Yamamoto; Katsuhiko Nosho; Hiroaki Kunimoto; Hiromu Suzuki; Yasushi Adachi; Mayumi Nakazawa; Takayuki Nobuoka; Mariko Kawayama; Masashi Mikami; Takashi Matsuno; Tadashi Hasegawa; Koichi Hirata; Kohzoh Imai; Yasuhisa Shinomura
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

Review 5.  [Advanced and Metastatic Lung Cancer – What is new in the Diagnosis and Therapy?].

Authors:  Sacha I Rothschild
Journal:  Praxis (Bern 1994)       Date:  2015-07-01

6.  Neuronal polarity is regulated by glycogen synthase kinase-3 (GSK-3beta) independently of Akt/PKB serine phosphorylation.

Authors:  Annette Gärtner; Xu Huang; Alan Hall
Journal:  J Cell Sci       Date:  2006-09-05       Impact factor: 5.285

7.  A novel long noncoding RNA AK001796 acts as an oncogene and is involved in cell growth inhibition by resveratrol in lung cancer.

Authors:  Qiaoyuan Yang; Enwu Xu; Jiabin Dai; Binbin Liu; Zhiyuan Han; Jianjun Wu; Shaozhu Zhang; Baoying Peng; Yajie Zhang; Yiguo Jiang
Journal:  Toxicol Appl Pharmacol       Date:  2015-04-15       Impact factor: 4.219

Review 8.  Potential molecular approaches for the early diagnosis of lung cancer (review).

Authors:  Chul Ho Oak; Donald Wilson; Hu Jang Lee; Ho-Ju Lim; Eun-Kee Park
Journal:  Mol Med Rep       Date:  2012-08-21       Impact factor: 2.952

9.  MiR-1180 promotes apoptotic resistance to human hepatocellular carcinoma via activation of NF-κB signaling pathway.

Authors:  Guosheng Tan; Linwei Wu; Jinfu Tan; Bing Zhang; William Chi-shing Tai; Shiqiu Xiong; Wei Chen; Jianyong Yang; Heping Li
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

Review 10.  Glycogen synthase kinase 3: a key regulator of cellular fate.

Authors:  J E Forde; T C Dale
Journal:  Cell Mol Life Sci       Date:  2007-08       Impact factor: 9.261

View more
  16 in total

1.  Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation.

Authors:  Zihan Zhou; Xianguo Zhou; Yanji Jiang; Moqin Qiu; Xiumei Liang; Qiuling Lin; Qian Guo; Cunli Nong; Rongrui Huo; Qian Chen; Haizhou Liu; Yingchun Liu; Shaoliang Zhu; Mengyun Wang; Hongping Yu
Journal:  Sci Rep       Date:  2020-07-14       Impact factor: 4.379

2.  The DGCR5 long noncoding RNA may regulate expression of several schizophrenia-related genes.

Authors:  Qingtuan Meng; Kangli Wang; Tonya Brunetti; Yan Xia; Chuan Jiao; Rujia Dai; Dominic Fitzgerald; Amber Thomas; Lindsey Jay; Heather Eckart; Kay Grennan; Yuka Imamura-Kawasawa; Mingfeng Li; Nenad Sestan; Kevin P White; Chao Chen; Chunyu Liu
Journal:  Sci Transl Med       Date:  2018-12-13       Impact factor: 17.956

3.  LncRNA DGCR5 suppresses neuronal apoptosis to improve acute spinal cord injury through targeting PRDM5.

Authors:  Huafeng Zhang; Wengang Wang; Ning Li; Peng Li; Ming Liu; Junwei Pan; Dan Wang; Junwei Li; Yuanyuan Xiong; Lei Xia
Journal:  Cell Cycle       Date:  2018-09-11       Impact factor: 4.534

4.  LncRNA SLC7A11-AS1 Contributes to Lung Cancer Progression Through Facilitating TRAIP Expression by Inhibiting miR-4775.

Authors:  Yongmin Liu; Xinglong Fan; Zheng Zhao; Xiu Shan
Journal:  Onco Targets Ther       Date:  2020-06-30       Impact factor: 4.147

5.  lncRNA DGCR 5/miR‑27a‑3p/BNIP3 promotes cell apoptosis in pancreatic cancer by regulating the p38 MAPK pathway.

Authors:  Xianjie Li; Shanxue Zhou; Tianyi Fan; Xuefeng Feng
Journal:  Int J Mol Med       Date:  2020-06-04       Impact factor: 4.101

6.  The effects of aberrant expression of LncRNA DGCR5/miR-873-5p/TUSC3 in lung cancer cell progression.

Authors:  Judong Luo; Hong Zhu; Hua Jiang; Yayun Cui; Mengjie Wang; Xinye Ni; Changsheng Ma
Journal:  Cancer Med       Date:  2018-05-23       Impact factor: 4.452

7.  Identification of a lncRNA‑associated competing endogenous RNA‑regulated network in clear cell renal cell carcinoma.

Authors:  Beibei Liu; Tantu Ma; Qingwen Li; Sheng Wang; Wei Sun; Wenyong Li; Jianmin Liu; Yuanyuan Guo
Journal:  Mol Med Rep       Date:  2019-05-23       Impact factor: 2.952

8.  MicroRNA-1180 is associated with growth and apoptosis in prostate cancer via TNF receptor associated factor 1 expression regulation and nuclear factor-κB signaling pathway activation.

Authors:  Deyuan Zhu; Wenxi Gao; Zhongmin Zhang
Journal:  Oncol Lett       Date:  2018-01-31       Impact factor: 2.967

9.  A Regulatory Axis of circ_0008193/miR-1180-3p/TRIM62 Suppresses Proliferation, Migration, Invasion, and Warburg Effect in Lung Adenocarcinoma Cells Under Hypoxia.

Authors:  Minbiao Chen; Xiuming Huang; Liang Li; Mingfang Huang; Renzhong Cai; Xuqiang Liao
Journal:  Med Sci Monit       Date:  2020-08-12

10.  Comprehensive evaluation of differential lncRNA and gene expression in patients with intervertebral disc degeneration.

Authors:  Zhigang Qu; Zhe Quan; Qi Zhang; Zhenyu Wang; Qingxu Song; Xinming Zhuang; Changfeng Fu; Feng Xu; Yadong Liu; Yuanyi Wang; Zheng Wang; Yi Liu
Journal:  Mol Med Rep       Date:  2018-06-05       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.